Metabolomics Market Study Offering Insights on Latest Advancements, Trends & Analysis from 2022 to 2028

This new report from Stratview Research analyses the Metabolomics Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Metabolomics Market Overview:

The metabolomics market was estimated at US$ 2.3 billion in 2021 and is expected to grow at a CAGR of 14.86% during 2022-2028 to reach US$ 6.18 billion in 2028.

Drivers

The following are the major players in the metabolomics market:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• Human Metabolome Technologies Inc.
• Metabolon, Inc.
• Shimadzu Corporation
• Waters Corporation

Segment Analysis

The market is divided based on product and service, technology, application, and end user. On the basis of product and service, the market is further segmented into metabolomics instruments, and metabolomics bioinformatics tools and services. The instruments segment is further divided into seperation tools and detection tools. The separation tools is segmented into high-performance liquid chromatography (HPLC), gas chromatography (GC), ultra-performance liquid chromatography (UPLC), capillary electrophoresis (CE). The detection tools is segmented into mass spectrometry, nuclear magnetic resonance spectroscopy (NMR), surface-based mass analysis.

Based on clinical indication, the metabolomics market has been divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The metabolomics market is mostly driven by cancer among the various clinical indications. The increased frequency of cancer worldwide and the expansion of oncological research efforts are the main causes of this. The World Health Organization (WHO) reports that cancer was the second biggest cause of death worldwide, accounting for 8.8 million fatalities. Cardiovascular problems, neurological conditions, inborn metabolic abnormalities, and other clinical indications for metabolomics are also included.

The metabolomics market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Due to factors including the presence of several financing sources from both public and private agencies, the accessibility of technologically cutting-edge products, and the dominance of some of the important firms in the region, North America is the largest market for metabolomics goods and services. The metabolomics market is anticipated to develop at the quickest rate during the forecast period in Asia-Pacific. Its expansion is primarily being driven by rising healthcare and R&D spending, an increase in the use of technology in clinical settings, and a growing interest among large businesses in exploring unexplored markets.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3168/metabolomics-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]